Axsome files Form 144 to sell 49,670 shares

Axsome Therapeutics filed a Form 144 reporting an intended sale of 49,670 shares of Common Stock.

Rhea-AI Filing Summary

Axsome Therapeutics filed a Form 144 reporting an intended sale of 49,670 shares of Common Stock. The shares were acquired on 03/15/2017 pursuant to stock options and the planned disposition is described as a cashless exercise / same-day sale. The filing lists 06/09/2026 as a related date.

Insights

Securities Compliance Analyst

Form 144 notice: an insider plans an exercise-and-sale of 49,670 shares acquired in 2017.

The filing shows 49,670 shares were acquired as compensation via stock options on 03/15/2017 and the proposed method is a cashless exercise / same-day sale. The Form 144 provides the regulatory notice required for sales by affiliates under Rule 144.

Timing and actual sale execution depend on broker/dealer processing and any Rule 144 volume or manner-of-sale limits; subsequent Form 4 or trade reports will show completion and proceeds.

Key Figures

Planned shares to be sold: 49,670 shares Acquisition date: 03/15/2017 Form-related date: 06/09/2026 +2 more

5 metrics

Planned shares to be sold 49,670 shares listed on Form 144

Acquisition date 03/15/2017 acquired as compensation via stock options

Form-related date 06/09/2026 date appearing in the filing header

Broker-dealer listed Goldman Sachs & Co. LLC broker-dealer named on the Form 144

Security type Common Stock security described on the Form 144

Key Terms

cashless exercise, same-day sale, Form 144

3 terms

cashless exercise financial

"Described as "Compensation -- Cashless exercise / same-day sale""

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

same-day sale financial

"Described as "cashless exercise / same-day sale""

Form 144 regulatory

"Header identifies filing as "144: Securities To Be Sold""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does Axsome's Form 144 report about insider activity?

The Form 144 reports a proposed sale of 49,670 shares of Common Stock acquired via stock options on 03/15/2017. It states the method as a cashless exercise / same-day sale and lists 06/09/2026 as a related date.

Does the Form 144 mean the shares have already been sold (AXSM)?

No; a Form 144 is a notice of an intended sale under Rule 144, not confirmation of a completed trade. Actual sale execution and proceeds will appear in subsequent trade reports or a Form 4 if required.

How many shares does the filing show were acquired and by what method?

The filing shows 49,670 shares were acquired as compensation through stock options on 03/15/2017. The planned disposition is labeled a cashless exercise / same-day sale in the notice.

Will Axsome receive proceeds from this sale reported on Form 144?

The Form 144 lists a planned sale by an insider via cashless exercise and same-day sale; it does not state the company will receive proceeds. Proceeds are generally received by the selling holder in resale transactions.

Where will I see confirmation if the sale occurs for AXSM insider shares?

Confirmation of an executed insider sale typically appears in subsequent SEC filings such as a Form 4 or in broker/dealer trade records. Look for a Form 4 or public trade reporting showing execution details and proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/09/2026 - 06:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001219927
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Axsome Therapeutics, Inc.
SEC File Number	001-37635
Address of Issuer	One World Trade Center 29th Floor New York NEW YORK 10007
Phone	1-212-332-3241
Name of Person for Whose Account the Securities are To Be Sold	Herriot Tabuteau
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	49670	12200938.8	51459766	06/09/2026	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/15/2017	Acquired as compensation -- Stock Options	The Issuer			49670	03/15/2017	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 3/10/2026, that is intended to comply with Rule 10b5-1(c).
Date of Notice	06/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Herriot Tabuteau
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)